Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by coalbeton Sep 14, 2018 12:42pm
100 Views
Post# 28621413

Start over in India!

Start over in India!

During the last decade, oncology research has undergone progressive globalization. It was estimated that an average of one million new cases of cancer are reported every year from India. Big Pharma in recent years is focussing on the conduct of oncology research in India. The country offers 700000 speciality sites, 221 medical colleges with trained and experienced English speaking medical staff and personal and state-of-an-art facilities and infrastructure for the conduct of oncology clinical trials in the country. The increase in medical tourism to India from the West supports the fact that India has state-of-an-art medical facilities and experienced medical staff.

Reasons for Clinical Trial Outsourcing to India

The various reasons for outsourcing clinical trials to India from the West:

• High rate of subject recruitment (nearly 7 times than in US)
• Treatment nave patient pool
• Occurrence of large number of cancer cases
• Huge unmet medical need
• Presence of high productive clinical trial sites
• Availability of skilful and trained investigators
• Increased standard of care
• Availability of cancer registries and databases
• Availability of stipulate regulations and regulatory bodies

Bullboard Posts